Bronchosol Maxipuren

Catarrh, sinus trouble
Sinuses

Bronchosol® MAXIPUREN

Medicinal product

Bronchosol Maxipuren packaging

Indications for use

Bronchosol MAXIPUREN is used:
– as an adjuvant in common cold and inflammations of the upper respiratory tract with accompanying cough, rhinitis and difficult expectoration of viscous mucus;
– as an adjuvant in non-purulent rhinosinusitis.
The product is indicated in adults and adolescents from 12 years of age.

Composition

One capsule of the medicinal product Bronchosol MAXIPUREN contains 200 mg Eucalyptus globulus Labill, Eucalyptus polybractea R.T. Baker, Eucalyptus smithii R.T. Baker, aetheroleum (eucalyptus oil).
Excipients with known effect:
sorbitol 70%; one capsule contains up to 14.77 mg of sorbitol,
propylene glycol; one capsule contains 5.20 mg of propylene glycol.

Dosage form and packaging

capsule
Form: gastro-resistant capsule, soft
Packaging: 30 capsules

Contraindications

Hypersensitivity to eucalyptus oil, its constituents (1,8-cineol) or to any of the excipients.

Dosage and route of administration

Who?
Dose
When?

Who?Adults and adolescents aged 12+Adults and adolescents aged 12+
Dosecapsule1 capsule
When?2-3 times a day

Children under 12 years of age: Do not use.
Duration of treatment: Bronchosol MAXIPUREN should be used until symptoms resolve, usually for 1 week.
Method of administration: Take the drug 15 minutes before a meal with water. Swallow whole, do not chew.
Duration of use: Consult a doctor if the symptoms persist or worsen after 7 days.

MARKETING AUTHORISATION HOLDER

Phytopharm Klęka S.A., Klęka 1, 63-040 Nowe Miasto nad Wartą

Before use, read the patient information leaflet. The leaflet contains indications, contraindications, information about adverse reactions and dosage, as well as directions for use. Otherwise consult a doctor or a pharmacist as every drug used incorrectly could pose a danger to your life and health.

 

BioaronDentosept Complex
FiordaPelafen